Walking Pneumonia Symptoms: The Cough That Outlasts the Cold

By the third week it isn’t a cold anymore. The cough is still there at six in the morning and still there at eleven at night, and the person doing the coughing has gone to work or school every day of it. That pattern is where the name came from. Walking pneumonia symptoms build slowly instead of landing all at once: a cough that starts dry and gradually worsens, along with fever, headache, sore throat, tiredness and mild shortness of breath. It is a mild lung infection, most often caused by the bacterium Mycoplasma pneumoniae, and the U.S. CDC explains the nickname in one line: “With mild symptoms, people may not stay home or in bed. Thus, the phrase ‘walking pneumonia’ was coined.” It can take 1 to 4 weeks for symptoms to appear after exposure, symptoms can last for several weeks after that, and CDC’s clinical guidance notes the disease can persist for months while still being frequently mild and self-resolving.

What walking pneumonia symptoms actually look like

CDC describes two pictures from the same bacterium. The more common one is a chest cold: feeling tired, fever, headache, a slowly worsening cough, and a sore throat. The less common one is pneumonia proper, listed as cough, feeling tired, fever and chills, and shortness of breath.

Clinically, the onset is “gradual and subacute.” The cough is “initially dry” and “may later produce moderate amounts of non-bloody sputum,” with breathlessness that stays mild. CDC adds the line that explains most of the confusion: someone who has it “may seem better than expected for someone with a lung infection.” No shaking chill, no single day where everything falls apart. Just a cough that refuses to finish.

The timeline is the giveaway

Influenza announces itself in hours. This does not. CDC puts the incubation period at “generally between 1 to 4 weeks,” with shorter and longer durations possible, so the exposure behind a mid-December cough may have happened before Thanksgiving. By the time anyone thinks to connect the two, the trail has gone cold.

The back end is just as loose. CDC says symptoms “can last for several weeks,” and its clinical signs page adds that “the disease can persist for months; however, it’s frequently mild and self-resolving.” Recovery from pneumonia in general, according to the NIH’s National Heart, Lung, and Blood Institute, runs one to two weeks for some people and a month or longer for others, and “most people continue to feel tired for about a month.” Worth planning around in a Maine winter, because easing back into winter exercise in northern New England is a different project from resuming it at full speed.

Seasonality gets stated more confidently than the evidence supports. The 2024 review says these infections “surge during winter months.” CDC’s own Mycoplasma pages name no season at all.

A cough with no clear start date also collects explanations. In January it gets pinned on dry heat, woodstoves, or something growing behind the basement wall, and indoor humidity and mold in New England homes deserve attention regardless. Push the same cough into April and it becomes allergies, because New Hampshire’s spring pollen season arrives right when a long winter infection would be wearing out its welcome. The distinction is not the calendar. It is whether the cough arrived alongside fever, headache and real fatigue.

Maine tracks three viruses, and this is not one of them

Maine CDC defines the respiratory virus season federally: it “starts the 40th MMWR week of the year and ends the 39th MMWR week of the next year,” meaning early October through late September. Its Respiratory Virus Dashboard updates every Wednesday by 3 pm and covers influenza, COVID-19 and RSV. That is the whole list.

Mycoplasma is not on it, and it is not on Maine’s Notifiable Diseases and Conditions List either, where the only pneumonia entry is “Streptococcus pneumoniae, invasive,” a different organism. Covering the gap are two lines at the bottom of that list: “Any Case of Unusual Illness of Infectious Cause” and “Any Cluster/Outbreak of Illness with Potential Public Health Significance.” Maine names Educational Institutions and Child Care Facilities among those who must report, by telephone to 1-800-821-5821, 24 hours a day.

Then there is the school guidance. Maine CDC’s Communicable Diseases Quick Guide for Schools and Child Care Centers has rows for COVID-19, pertussis, strep throat and chickenpox. The words “pneumonia” and “Mycoplasma” appear nowhere in it. The closest comparison is the pertussis row, with its “4-21 days” incubation and “coughing that may last weeks to months.” The guide does set the number a parent actually uses: fever means “a temperature of 100.4 degrees F (38 degrees C) or higher,” and fever free means “Fever free for 24 hours without the use of fever suppressing medications.”

That is not a failure of the state, since no national system exists either. CDC says there “is no national reporting or surveillance system for Mycoplasma pneumoniae infections,” while estimating roughly 2 million M. pneumoniae infections nationwide each year, most of them chest colds rather than pneumonia. Which is how a cough that outlasts the cold ends up in a blind spot in a Maine classroom. Federal data rated acute respiratory illness activity in both Maine and New Hampshire “Very Low” for the week ending August 29, 2026, the baseline this season starts from.

The 2024 wave, and where it went

CDC reports cases climbing in “late spring/early summer of 2024,” with diagnosed infections peaking “for the 2-4-year-old and 5-17-year-old age groups in August 2024,” and it flagged the rise among the youngest children as “notable because these infections have historically been thought to affect school-age more than younger children.” Federal emergency department data give the scale. Pneumonia accounted for 4.7 percent of ED visits by children aged 5 to 17 in the week ending November 30, 2024, up from 1.6 percent that August.

The wave has receded. In that dataset, pneumonia peaked at 1.7 percent of visits by children 5 to 17 in the week ending December 27, 2025, roughly a third of the 2024 high, and CDC reports infections decreasing since early 2025 while still running above their usual level in some U.S. regions. How often this repeats is unsettled: CDC’s surveillance page says peaks arrive “every 3 to 7 years,” its clinical overview says about every four, and the 2024 review says roughly every one to four years.

Who looks the least sick

Children under five often do not get pneumonia at all. CDC says infections in that group “may run subclinical, be mild, and not result in pneumonia,” and the symptoms it lists read like a head cold: a stuffy or runny nose without fever, sneezing, watery eyes and sore throat, plus diarrhea, vomiting and wheezing. In the New England Journal of Medicine’s EPIC study of U.S. children hospitalized with pneumonia, M. pneumoniae turned up in 19 percent of those aged 5 and older against 3 percent of the younger ones. A narrow denominator, hospitalized children only, but the pattern holds. The 2024 review calls this organism the leading cause of community-acquired pneumonia among school-aged children and young adults.

Older adults run the other way. NHLBI notes that older and immunocompromised people “may have a lower-than-normal temperature instead of a fever,” and that “older adults who have pneumonia may feel weak or suddenly confused.” Sudden confusion in an older relative is not a minor symptom here. It can be the loudest one.

Setting matters too. CDC lists college residence halls, correctional facilities, hospitals, long-term care facilities, military training facilities and schools as where outbreaks happen. Brief contact with someone who is sick rarely spreads it, but “people who spend a lot of time together are at increased risk.”

When guidance says to check in

NHLBI’s advice is short. Call your provider if your symptoms suddenly get worse, or if you have trouble breathing or talking. That carries more weight here than usual, because the illness is defined by not feeling bad enough to stop. The signal is a change in direction, not the severity on any single day.

Serious complications are uncommon, though CDC says they “can result in hospitalization and sometimes death,” and the list reaches outside the lungs: encephalitis, hemolytic anemia, kidney dysfunction, septic arthritis, asthma exacerbation, and a mucous membrane and skin reaction called reactive infectious mucocutaneous eruption. A review in Clinical Microbiology Reviews notes those manifestations “are sometimes of greater severity” than the respiratory infection itself. Rare, but a new symptom elsewhere in the body may not be unrelated to the cough.

Why the familiar antibiotic does not apply

One piece of biology explains a lot of frustrated phone calls. M. pneumoniae, CDC says, lacks a rigid cell wall, so “antimicrobials that target the cell wall (i.e., beta-lactam antibiotics) don’t work against these bacteria.” That rules out the penicillin family, which is what most people picture when they hear the word antibiotic. CDC also states that most infections of this kind are self-limiting.

Resistance coverage deserves a careful read. International reporting cites alarming figures, and the 2024 review records resistance above 80 percent of cases in China. CDC’s figure for this country is different: resistance “has remained under 10% in United States.” A number from another continent is not a number about a cough in Bangor, and what fits any given person is a conversation with a clinician.

Sources

• U.S. Centers for Disease Control and Prevention. About Mycoplasma pneumoniae Infection. https://www.cdc.gov/mycoplasma/about/index.html
• U.S. Centers for Disease Control and Prevention. Clinical Signs of Mycoplasma pneumoniae Infection. https://www.cdc.gov/mycoplasma/hcp/clinical-signs/index.html
• U.S. Centers for Disease Control and Prevention. Clinical Overview of Mycoplasma pneumoniae Infection. https://www.cdc.gov/mycoplasma/hcp/clinical-overview/index.html
• U.S. Centers for Disease Control and Prevention. Clinical Care of Mycoplasma pneumoniae Infection. https://www.cdc.gov/mycoplasma/hcp/clinical-care/index.html
• U.S. Centers for Disease Control and Prevention. How Mycoplasma pneumoniae Spreads. https://www.cdc.gov/mycoplasma/causes/index.html
• U.S. Centers for Disease Control and Prevention. Mycoplasma pneumoniae Surveillance. https://www.cdc.gov/mycoplasma/php/surveillance/index.html
• U.S. Centers for Disease Control and Prevention. Respiratory Conditions Treated in the Emergency Department, National Syndromic Surveillance Program (dataset v58w-vynu). https://data.cdc.gov/d/v58w-vynu
• U.S. Centers for Disease Control and Prevention. Level of Acute Respiratory Illness Activity by State (dataset f3zz-zga5). https://data.cdc.gov/d/f3zz-zga5
• Maine CDC. Respiratory Virus Dashboard. https://www.maine.gov/dhhs/mecdc/data-reports/diseases/infectious-disease/respiratory-dashboard
• Maine CDC. Notifiable Diseases and Conditions List (6-4-25). https://www.maine.gov/dhhs/mecdc/sites/maine.gov.dhhs.mecdc/files/Notifiable-Conditions-List-6-4-25.pdf
• Maine CDC. Communicable Diseases Quick Guide for Schools and Child Care Centers in Maine. https://www.maine.gov/dhhs/mecdc/sites/maine.gov.dhhs.mecdc/files/epi/Communicable-Diseases-Quick-Guide.pdf
• National Heart, Lung, and Blood Institute, National Institutes of Health. Pneumonia: Recovery. https://www.nhlbi.nih.gov/health/pneumonia/recovery
• National Heart, Lung, and Blood Institute, National Institutes of Health. Pneumonia: Symptoms. https://www.nhlbi.nih.gov/health/pneumonia/symptoms
• Rowlands RS, Meyer Sauteur PM. Mycoplasma pneumoniae: not a typical respiratory pathogen. J Med Microbiol. 2024;73(10):001910. https://pubmed.ncbi.nlm.nih.gov/39475213/
• Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45. https://pubmed.ncbi.nlm.nih.gov/25714161/
• Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728. https://pubmed.ncbi.nlm.nih.gov/15489344/

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.